EventBusinessSeptember 16, 2026

Novo Nordisk taps Anthropic AI to speed drug development

Novo Nordisk will use Claude and Claude Science across drug discovery, R&D, and software engineering, per reports on the partnership. The Ozempic and Wegovy maker is aiming to catch up in the obesity market.

How this story unfolded

2 days · 4 reports · 3 community posts · from Sep 16

  1. Sep 16
  2. Sep 17
  3. Sep 18

More stories today

Open the live feed